Add To Cart

Section 4
Withdrawal Symptoms, Dependency Risk

Question 4 | Test | Table of Contents

U.S. Department of Veterans Affairs 

If you wish to increase the text size of this publication, maximize your window.
Click outside the box below, press Ctrl “+” several times, then scroll.
Questions? Email:

- Marcel O. Bonn-Miller, Ph.D. Cannabis & PTSD: Existing Evidence and Clinical Considerations. U.S. Department of Veterans Affairs, 2016, p29-34.

Peer-Reviewed Journal Article References:
Budney, A. J., Moore, B. A., Vandrey, R. G., & Hughes, J. R. (2003). The time course and significance of cannabis withdrawal. Journal of Abnormal Psychology, 112(3), 393–402.

Carey, C. E., Agrawal, A., Zhang, B., Conley, E. D., Degenhardt, L., Heath, A. C., Li, D., Lynskey, M. T., Martin, N. G., Montgomery, G. W., Wang, T., Bierut, L. J., Hariri, A. R., Nelson, E. C., & Bogdan, R. (2015). Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis. Journal of Abnormal Psychology, 124(4), 860–877.

Herrmann, E. S., Weerts, E. M., & Vandrey, R. (2015). Sex differences in cannabis withdrawal symptoms among treatment-seeking cannabis users. Experimental and Clinical Psychopharmacology, 23(6), 415–421. 

What are True Cannabis Withdrawals? To select and enter your answer go to Test